JA
VIVO

JOYN Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

JOYN Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-68
Closed -$1K – 1556
2018
Q4 		$1K Sell
68
-34
-33% -$580 ﹤0.01% 1700
2018
Q3 		$2K Sell
102
-17
-14% -$264 ﹤0.01% 1516
2018
Q2 		$2K Buy
+119
New +$1.77K ﹤0.01% 1480

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

JOYN Advisors's VIVO Position: Q1 2019 in Review

JOYN Advisors sold out of Meridian Bioscience Inc (VIVO) in Q1 2019, closing a stake of 68 shares — an estimated $1K sold.

JOYN Advisors first reported a position in VIVO in Q2 2018 and held it in 3 quarters. The position peaked at $2K in Q3 2018. 183 funds tracked by Wall St. Rank hold VIVO as of Q1 2019.

  • JOYN Advisors reported no remaining Meridian Bioscience Inc position as of Q1 2019 after selling out during the quarter.
  • JOYN Advisors sold 68 Meridian Bioscience Inc shares in Q1 2019, an estimated $1K.
  • JOYN Advisors first reported a position in Meridian Bioscience Inc in Q2 2018 and held it in 3 quarters.
  • JOYN Advisors's Meridian Bioscience Inc position peaked at $2K in Q3 2018.
  • 183 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2019.

Based on JOYN Advisors's 13F filing for Q1 2019, filed 9 May 2019.